Mobile Menu

Search Results

Search results for: Patients

“Our geneticist could only find three published articles about the GRIN1 gene at the time” – Interview with Jillian Hastings Ward, Chair of the Participant Panel at Genomics England

Jillian Hastings Ward is Chair of the Participant Panel at Genomics England. The Panel acts as an advisory body to the Genomics England board to ensure that the data collected by the 100,000 Genomes Project is being used for the best interests of the participants.

Partner with Us

*** To request our Media Kit or to find out more about partnering with us, email Beth or call her on […]

Transforming R&D with Data

With the cost of developing a drug doubling every 9 years, the pharma business model will soon become largely unsustainable. […]

Microbial DNA in blood samples may reveal who has cancer, and which type

The study, published in Nature yesterday, may change how cancer is diagnosed, and shape our understanding of how cancer interacts with microbes.

Shareable Science: COVID-19 Q&A Session

As headlines trumpet the continued spread of COVID-19, the wall-to-wall coverage has generated a secondary outbreak of breathless hype, misinformation and anxiety.

CRUK funds development of POC blood-based brain cancer test

Cancer Research UK (CRUK) has funded a project run by a team of researchers at the University of Bristol to […]

SARS-CoV-2 assay cleared for clinical use in Singapore

Singapore’s Health Sciences Authority has authorised clinical use of a new test for SARS-CoV-2 according to the Agency for Science, Technology, and Research (A*STAR).

Genetic sequencing of novel coronavirus indicates “undetected spread” in the US

Recent analysis of the genetic sequence of the coronavirus has indicated that the infection may have spread further than we realised. 

Genetic map of eight psychiatric disorders released

Around 25% of the world is affected by a psychiatric disorder that can alter their behaviour, social relations and intellectual ability.

Enabling Precision medicine for everyone: New pharmacogenomics solution launched in the US

The PGx program is an industry-first solution that will protect patients from being prescribed ineffective or harmful drugs.